CharlesA.LinkerMD
Oncology • San Francisco, CAHematologists at UCSF Medical Center Ambulatory Care Center
Are you Dr. Linker?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 38 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
400 Parnassus Ave
San Francisco, CA 94143Phone+1 415-353-2421Fax+1 415-353-2467- Is this information wrong?
Summary
- Dr. Charles Linker, MD is an oncologist in San Francisco, California. He is currently licensed to practice medicine in California.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1977 - 1978- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1974 - 1976
Stanford University School of MedicineClass of 1974
Certifications & Licensure
CA State Medical License 1975 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission Start of enrollment: 1996 Jun 01
- Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma Start of enrollment: 2003 Mar 01
- Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia Start of enrollment: 2005 May 01
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsLong-Term Follow-up of CALGB (Alliance) 100001: Autologous Followed by Nonmyeloablative Allogeneic Transplant for Multiple MyelomaSarah A. Holstein, Vera J. Suman, Kouros Owzar, Katelyn Santo, Don M. Benson, Thomas C. Shea, Thomas Martin, Margarida Silverman, Luis Isola, Ravi Vij, Bruce D. Cheson...> ;Biology of Blood and Marrow Transplantation. 2020 Aug 1
- 117 citationsUpdated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a...Sarah A. Holstein, Sin-Ho Jung, Paul G. Richardson, Craig C. Hofmeister, David D. Hurd, Hani Hassoun, Sergio Giralt, Edward A. Stadtmauer, Daniel J. Weisdorf, Ravi Vij...> ;The Lancet. Haematology. 2017 Sep 1
- 86 citationsPhase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen:...Steven M. Devine, Kouros Owzar, William Blum, Flora Mulkey, Richard Stone, Jack W. Hsu, Richard E. Champlin, Yi-Bin Chen, Ravi Vij, James L. Slack, Robert J. Soiffer, ...> ;Journal of Clinical Oncology. 2015 Dec 10
- Join now to see all
